Presentation TCT 2019 TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes Presenter: Alexandre Abizaid September 25, 2019
Presentation TCT 2019 TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry Presenter: Stefan Verheye September 25, 2019
Presentation TCT 2019 TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA Presenter: Takahiro Jimba September 25, 2019
Presentation TCT 2019 TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial Presenter: Jens Wiebe September 25, 2019
Presentation TCT 2019 TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results Presenter: Bernhard Witzenbichler September 25, 2019
Presentation TCT 2019 TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial Presenter: Abdelhakim Allali September 25, 2019
Presentation TCT 2019 TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial Presenter: Azfar Zaman September 25, 2019
News Opinion Fellow Talk What I Am Most Looking Forward to at TCT 2019 Mahesh V. Madhavan, MD September 18, 2019
News Daily News More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry Michael O'Riordan August 14, 2019
Podcast TCTMD Talking Points COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions July 17, 2019
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
Podcast TCTMD Talking Points TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population May 15, 2019
News Daily News Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow Michael O'Riordan April 30, 2019
Presentation CIT 2019 A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes Presenter: Bo Xu March 29, 2019
Presentation CIT 2019 A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT Presenter: Yaling Han March 28, 2019
Presentation OPCI 2019 Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon Angioplasty to Bioresorbable Scaffolds Presenter: Gary S. Mintz March 09, 2019
News Daily News FDA Approves Orsiro Ultrathin-Strut Stent for CAD Michael O'Riordan February 22, 2019